Charles Schwab
OCEA

Charles Schwab’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Charles Schwab’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,305
Closed -$99.6K – 3694
2024
Q1 		$99.6K Hold
26,305
– – ﹤0.01% 3305
2023
Q4 		$17.4K Hold
26,305
– – ﹤0.01% 3496
2023
Q3 		$103K Sell
26,305
-41,224
-61% -$189K ﹤0.01% 3350
2023
Q2 		$406K Buy
+67,529
New +$396K ﹤0.01% 3146

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab's OCEA Position: Q2 2024 in Review

Charles Schwab sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2024, closing a stake of 26,305 shares — an estimated $99.6K sold.

Charles Schwab first reported a position in OCEA in Q2 2023 and held it in 4 quarters. The position peaked at $406K in Q2 2023. 36 funds tracked by Wall St. Rank hold OCEA as of Q2 2024.

  • Charles Schwab reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Charles Schwab sold 26,305 Ocean Biomedical, Inc. Common Stock shares in Q2 2024, an estimated $99.6K.
  • Charles Schwab first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Charles Schwab's Ocean Biomedical, Inc. Common Stock position peaked at $406K in Q2 2023.
  • 36 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2024.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.